⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASND News
Ascendis Pharma A/S American Depositary Shares
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
globenewswire.com
ASND
V2 Communications to Host Webinar on CEO Visibility as a Business Imperative
globenewswire.com
RKT
ASND
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
globenewswire.com
ASND
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
globenewswire.com
ASND
ATI Engage® Honored for Advancing Digital Learning in Nursing Education
globenewswire.com
ASND
Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026
globenewswire.com
ASND
International Bridge and Asendia USA Collaborate to Expand Non-Continental U.S. Delivery Capabilities
prnewswire.com
ASND
Ascendion Appraised at CMMI® Maturity Level 5 Reflecting Discipline Behind AI in Production
prnewswire.com
ASND
Stimvia erweitert den wissenschaftlichen Beirat und die kommerzielle Führung, um die globale Marktexpansion der Flaggschiff-Therapie URIS® voranzutreiben USA - Deutsch USA - español USA - English USA - English USA - Français
prnewswire.com
MDT
SYK
ASND
Stimvia impulsará la expansión global de su terapia insignia URIS® USA - español USA - Français
prnewswire.com
MDT
SYK
ASND